Release date: 24 June 2021
Promoter – Financial Intermediary
ANACONDA BIOMED SLLocation
Description
The project consists of financing the development of a new innovative catheter.
Objectives
The proposed transaction will support research and development (R&D), manufacturing and product development costs for Anaconda, a company based in Spain based which develops a catheter system for mechanical thrombectomy.
Sector(s)
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 10 million
Total cost (Approximate amount)
EUR 17 million
Environmental aspects
The Promoter's investments concern research, development and innovation activities that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during appraisal.
Procurement
The Promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not covered by the EU directives on procurement. However, the Promoter's procurement procedures are expected to be in line with EIB guidelines for private sector projects. The Bank's services will verify details during the project due diligence.
Status
Approved - 5/07/2021
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).